These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11353816)

  • 21. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
    Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
    Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).
    Cano-Soldado P; Lorráyoz IM; Molina-Arcas M; Casado FJ; Martinez-Picado J; Lostao MP; Pastor-Anglada M
    Antivir Ther; 2004 Dec; 9(6):993-1002. PubMed ID: 15651758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
    Magné N; Fischel JL; Dubreuil A; Formento P; Ciccolini J; Formento JL; Tiffon C; Renée N; Marchetti S; Etienne MC; Milano G
    Clin Cancer Res; 2003 Oct; 9(13):4735-42. PubMed ID: 14581344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between AUC of 5'-DFUR and toxicity of capecitabine, fluoropyrimidine carbamate analogs, and 5'-DFUR in monkeys, mice, and rats.
    Shindoh H; Kawashima A; Shishido N; Nakano K; Kobayashi K; Horii I
    J Toxicol Sci; 2006 Aug; 31(3):265-85. PubMed ID: 16960436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine.
    Ninomiya Y; Miwa M; Eda H; Sahara H; Fujimoto K; Ishida M; Umeda I; Yokose K; Ishitsuka H
    Jpn J Cancer Res; 1990 Feb; 81(2):188-95. PubMed ID: 2139643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.
    Shimma N; Umeda I; Arasaki M; Murasaki C; Masubuchi K; Kohchi Y; Miwa M; Ura M; Sawada N; Tahara H; Kuruma I; Horii I; Ishitsuka H
    Bioorg Med Chem; 2000 Jul; 8(7):1697-706. PubMed ID: 10976516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine: preclinical pharmacology studies.
    Ishitsuka H
    Invest New Drugs; 2000 Nov; 18(4):343-54. PubMed ID: 11081570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
    Knikman JE; de Vries N; Rosing H; Cats A; Guchelaar HJ; Beijnen JH
    Pharmazie; 2023 Aug; 78(8):107-112. PubMed ID: 37592424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro liver model on microfluidic device for analysis of capecitabine metabolite using mass spectrometer as detector.
    Zhang J; Wu J; Li H; Chen Q; Lin JM
    Biosens Bioelectron; 2015 Jun; 68():322-328. PubMed ID: 25599844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.
    Hung SW; Marrache S; Cummins S; Bhutia YD; Mody H; Hooks SB; Dhar S; Govindarajan R
    Cancer Lett; 2015 Apr; 359(2):233-40. PubMed ID: 25600708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
    Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
    Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
    Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
    Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.
    Evrard A; Cuq P; Ciccolini J; Vian L; Cano JP
    Br J Cancer; 1999 Aug; 80(11):1726-33. PubMed ID: 10468288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discovery and development of novel anticancer drug capecitabine].
    Ishitsuka H; Shimma N; Horii I
    Yakugaku Zasshi; 1999 Dec; 119(12):881-97. PubMed ID: 10630095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
    Vainchtein LD; Rosing H; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2010 Apr; 24(4):374-86. PubMed ID: 19650151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2.
    Loewen SK; Ng AM; Yao SY; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1999 Aug; 274(35):24475-84. PubMed ID: 10455109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.
    Zufía L; Aldaz A; Giráldez J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):51-8. PubMed ID: 15282093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.